Turmeric Extract · Theracurmin · BCM-95
Curcumin is the principal curcuminoid in turmeric (Curcuma longa), a flowering plant in the ginger family used in Asian cuisine and Ayurvedic medicine for thousands of years. Curcumin (and the related demethoxy- and bisdemethoxycurcumin) is responsible for turmeric's yellow color and most of its medicinal properties. It accounts for only ~3% of turmeric by weight - eating turmeric provides minimal therapeutic curcumin.
Starting dose. Longvida 400mg 1-2x daily, OR Meriva 500mg 2x daily
Take with a meal containing fat for best absorption (curcumin is fat-soluble). Longvida has reduced food dependence. Split dosing maintains steadier plasma levels for chronic inflammatory conditions.
Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.
Curcumin's primary anti-inflammatory mechanism is inhibition of NF-kB (nuclear factor kappa-B), the master transcription factor for inflammatory cytokine production. This downregulates TNF-alpha, IL-1, IL-6, COX-2, iNOS, and other inflammatory mediators across multiple cell types.
COX-2 inhibition: curcumin selectively inhibits COX-2 (the inducible inflammatory cyclooxygenase) without significant COX-1 inhibition - giving NSAID-like anti-inflammatory effect without GI bleeding risk.
Antioxidant: curcumin directly scavenges ROS, induces phase II antioxidant enzymes via Nrf2 pathway (heme oxygenase-1, glutathione-S-transferases), and chelates transition metals.
Endothelial function: curcumin upregulates eNOS (endothelial nitric oxide synthase), improving NO production, vasodilation, and endothelial health. Direct relevance for cardiovascular and erectile function.
Cancer-related pathways: curcumin modulates STAT3, Wnt/beta-catenin, p53, and apoptosis-regulating pathways. In vitro and animal data show selective tumor cell apoptosis induction. Human cancer data is preliminary.
Brain effects (Longvida): SLCP form crosses BBB and accumulates in brain tissue. Animal models show reduced amyloid plaques, neuroinflammation, and improved cognition. Small human RCTs show modest cognitive improvement.
Microbiome: curcumin modulates gut microbiota composition, supporting beneficial bacteria. Most curcumin in the gut acts locally before being metabolized.
Weeks 1-2: Subtle anti-inflammatory effects.
Each reference below was re-fetched from its PubMed record, and the quoted sentence was confirmed to appear in that abstract and to support the claim it sits under. Follow any of them to read the source.
Longvida solid-lipid curcumin capsules were administered at 400 mg twice daily for 90 days.
Patients and methods: Eligible patients fulfilling American College of Rheumatology Criteria were randomized to SLCP group (400 mg twice daily delivering 80 mg of curcumin per capsule) or Ibuprofen with placebo group (400 mg each once daily) for 90 days.
Evidence scope. Human knee-osteoarthritis pilot; exact branded formulation and schedule, not evidence for the Meriva alternative.
One Longvida participant withdrew because of rash and itching; otherwise the study drug was described as safe.
Except one withdrawal in the study group due to rash and itching, the study drug was found safe.
Evidence scope. Small 90-day pilot; does not establish uncommon harms, anticoagulant interactions, or long-term safety.
Claims we could not support
No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.
Mechanism: NF-kB/COX-2 inhibition, Nrf2 activation, and eNOS upregulation. No checked Longvida abstract directly supported this composite mechanism; the exact-dose trial found no significant change in measured inflammatory markers.
Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.
Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.
Standard curcumin: <2 hours (rapidly conjugated). Longvida: ~6 hours (free curcumin form). Meriva: ~3-4 hours.
Standard: ~1-2 hours. Longvida: ~3 hours. Meriva: ~2-4 hours.
For most forms. Tissue effects on inflammation persist longer.
Standard curcumin: ~1%. Longvida: ~65x standard (free curcumin form). Meriva: ~29x. Theracurmin: ~27x. BCM-95: ~7x. C3+Bioperine: ~20x.
Acute anti-inflammatory effects: 4-12 hours per dose. Chronic effects on joint/cognitive/hepatic outcomes build over 4-12 weeks.
Extensive Phase II conjugation (glucuronidation, sulfation) in intestine and liver. Biliary excretion of metabolites.
Storage. Store at room temperature (20-25C) in a cool, dry place. Protect from light - curcumin is photosensitive. Capsules shelf-stable 2+ years. Liquid phytosome forms similarly stable.
Classified as a dietary supplement in the US. Curcumin and turmeric are GRAS (Generally Recognized as Safe) for food use. No FDA-approved medical indication, though widely used as alternative to NSAIDs for arthritis.
Put it to work
Open Curcumin (Longvida) straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.
Open Curcumin (Longvida) in the app →Go deeper
The complete Curcumin (Longvida) walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.
Join the community ↗Track it in OnePin. Log vials, draws, and protocols in the app.
Type a name, brand, or tool. Esc closes.